The future of oncology appears to hinge on Molecular Medicine (MM), which is founded on three pillars: medical science, molecular biology, and Systems Biomedicine. The latter involves multilevel models that integrate factors from molecular to phenotypic levels, utilizing tools from bioinformatics, statistics, and interdisciplinary sciences like Mathematical Oncology and Systems Biology.
